CClinicalTrials.gg
CompletedNCT04642885FACT-ADUpdated Dec 18, 2024

Families Coping Together With Alzheimer's Disease

An observational study in Family Research and Dementia, sponsored by Yale University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-18.

Sponsored by Yale University · Observational

Study type
Observational
Model
Family-based
Time perspective
Prospective
Enrollment
354
Ages
18 Years and older
Sex
All
01

Study summary

Two remote phone/zoom calls are required to assess experiences as a family coping with dementia.

Read the detailed description

Using a combination of paper or online surveys in addition to interactive visits with blood pressure monitoring, participants are observed interacting with each other. Blood pressure devices are mailed to their homes and only worn for six minute intervals. The first visit generally lasts one hour and the second visit 90 minutes.

02

Conditions studied

  • Family Research
  • Dementia

Browse trials for

03

In context

Alzheimer Disease

3,678 studies on the registry are indexed under Alzheimer Disease; 872 are open to participants now.

This study's enrollment of 354 is above the median of 200 across 751 observational studies indexed under Alzheimer Disease.

Browse Alzheimer Disease studies →

Lead sponsor

Yale University is the lead sponsor of 1,724 studies on the registry; 298 are open to participants now.

Of its 210 completed or terminated interventional studies of FDA-regulated products, 126 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

In this study, adult children of a parent over 55 with early stage dementia who are responsible for helping parent with at least one task will be recruited

Inclusion criteria

  • Parent must be 55 plus with symptoms or a diagnosis of dementia
  • Adult child must be over 18 and involved in some way with assisting parent.

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Observational model
Family-based
Time perspective
Prospective
Enrollment
354 participants (actual)
Patient registry
No

Groups and cohorts

  • dyad

    parent with dementia and an adult child who is a caregiver

06

What researchers measure

Primary outcomes

  1. Caregiver demand appraisals

    (1a) Caregiver demand appraisals: 6 items from the 12-item Zarit Burden Interview (ZBI) will assess caregiver appraisals of demands (e.g., That because of the time you spend with your relative that you don't have enough time for yourself?". Caregivers self-report aspects of burden on a scale from 0 (never) to 4 (nearly always; α= .86). Higher numbers indicate higher demands. Administration is 2.5 minutes

    Time frame: Baseline and one year

  2. Caregiver perceived stress

    (1b) Caregiver perceived stress: 6 items from the 12-item Zarit Burden Interview (ZBI) will assess caregiver perceived stress (e.g., "Stressed between caring for your relative and trying to meet other responsibilities (work/family)?"). Caregivers self-report aspects of burden on a scale from 0 (never) to 4 (nearly always; α= .86). Higher numbers indicate higher stress. Administration is 2.5 minutes.

    Time frame: Baseline and one year later

  3. Caregiver negative Coping

    The Brief COPE Inventory is a shortened version (28 items) of the COPE inventory in which respondents indicate how often they use a particular coping strategy under stress as ranked on a 4-point scale with 1 (I haven't been doing this at all) to 4 (I've been doing this a lot). Examples of items include "I've been using alcohol or drugs to help me get through it." and "I've been criticizing myself" (α=0.72, 0.84, 0.75 for emotion, problem, and dysfunction focused subscales). Higher scores indicate poorer coping. Administration is 10 minutes

    Time frame: Baseline and one year later

Secondary outcomes

  1. Relational Functioning

    The Relationships Inventory will measure the degree to which individuals perceive that they can rely on their parent or child for help and support when needed (e.g., "to what extent can you count on your parent/child for help with a problem?" "to what extent can you count on your parent/child to give you honest feedback, even when you might not want to hear it?"). Ratings will be made on a scale from 1 (not at all) to 5 (very much; α=.79). Four additional items will assess the degree to which individuals perceive that their parent/child is a good support-provider (e.g., "overall, my parent/child is a good support-provider" using a scale from 1 (strongly disagree) to 7 (strongly agree). Higher numbers indicate higher relationship functioning. Administration is 5 minutes.

    Time frame: Baseline and one year later

  2. Health

    Health-related quality of life will be assessed using the 12-item Short Form Survey (SF-12) version 1.0, documenting the extent of limitations in a number of domains. Higher scores indicate better physical and mental health-related quality of life. It has been used with both persons with ADRD and caregivers. Administration is 5 minutes. The minimum and maximum scores are 0 and 100.

    Time frame: Baseline and one year later

07

Study locations

1 site
  • Yale school of Public Health
    New Haven, Connecticut 06511, United States
08

References and documents

Study documents

  • Informed consent form · Jul 6, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04642885
Lead sponsor
Yale University
Collaborators
National Institute on Aging (NIA), National Institutes of Health (NIH), Department of Health and Human Services
Responsible party
Sponsor
First posted
Nov 24, 2020
Start date
Jun 30, 2019
Primary completion
Nov 30, 2023
Completion
Nov 30, 2024
Last update
Dec 18, 2024

Study contacts

Joan Monin, PhD
principal investigator · Yale University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion